China Shenhua Energy (01088) expects its net profit attributable to shareholders for the first half of the year to be between 28.4 billion yuan and 31.9 billion yuan.
China Shenhua (01088) announced that the expected net profit attributable to the owners of the company in the first half of 2026 is estimated to be between RMB 28.4 billion and RMB 31.9 billion. Compared to the statutory disclosure data for the same period last year (RMB 26.706 billion in the first half of 2025), this represents an increase of 6.3% to 19.4%. Compared to the restated data for the same period last year (RMB 30.478 billion in the first half of 2025), this represents a decrease of 6.8% to an increase of 4.7%.
China Shenhua Energy (01088) announced that it is expected that the net profit attributable to the owners of the company in the first half of 2026 will be between RMB 28.4 billion and RMB 31.9 billion. Compared to the legally disclosed data for the same period last year (RMB 26.706 billion in the first half of 2025), this represents a growth of 6.3% to 19.4%. Compared to the restated data for the same period last year (RMB 30.478 billion in the first half of 2025), this represents a decrease of 6.8% to an increase of 4.7%.
In the first half of 2026, the favorable factors affecting the net profit attributable to the owners of the company were mainly the increase in the volume of coal chemical business and the profits of coal chemical and transportation business due to the increase in the volume of self-owned railways, ports, and shipping business compared to the same period last year. The unfavorable factors affecting the net profit attributable to the owners of the company were mainly the increase in taxes and surcharges compared to the same period last year, as well as an increase in other expenses.
Related Articles

CHENMING PAPER (01812) expects a net loss attributable to the parent company of 700 million to 800 million yuan in the first half of the year.

Pusen Medical's Science and Technology Innovation Board IPO has already received inquiries, focusing on the research and development and manufacturing of disposable medical endoscopes.

Impression DHP (02695): Approximately 43.42 million restricted shares will be tradable starting July 17th.
CHENMING PAPER (01812) expects a net loss attributable to the parent company of 700 million to 800 million yuan in the first half of the year.

Pusen Medical's Science and Technology Innovation Board IPO has already received inquiries, focusing on the research and development and manufacturing of disposable medical endoscopes.

Impression DHP (02695): Approximately 43.42 million restricted shares will be tradable starting July 17th.

RECOMMEND





